USD 7.51
(-3.84%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2022 | 80.77 Million USD | 0.0% |
2020 | 53.96 Million USD | -30.1% |
2019 | 77.2 Million USD | 0.0% |
2017 | 19.14 Million USD | 43.47% |
2016 | 13.34 Million USD | 11.63% |
2015 | 11.95 Million USD | 29.07% |
2014 | 9.26 Million USD | 4.87% |
2013 | 8.83 Million USD | -18.01% |
2012 | 10.77 Million USD | 1.08% |
2011 | 10.65 Million USD | 35.14% |
2010 | 7.88 Million USD | 50.68% |
2009 | 5.23 Million USD | -11.52% |
2008 | 5.91 Million USD | 2.81% |
2007 | 5.75 Million USD | -34.27% |
2006 | 8.75 Million USD | -9.03% |
2005 | 9.62 Million USD | 0.0% |
2003 | 4.86 Million USD | 2772.4% |
2002 | 169.38 Thousand USD | -74.72% |
2001 | 670 Thousand USD | 771.65% |
2000 | 76.86 Thousand USD | -67.39% |
1999 | 235.7 Thousand USD | -36.6% |
1998 | 371.78 Thousand USD | 282.65% |
1997 | 97.15 Thousand USD | -30.01% |
1996 | 138.81 Thousand USD | 9.69% |
1995 | 126.54 Thousand USD | -54.56% |
1994 | 278.47 Thousand USD | 33.93% |
1993 | 207.92 Thousand USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 Q2 | 29.89 Million USD | 10.62% |
2023 Q3 | 31.45 Million USD | 5.22% |
2023 Q1 | 27.02 Million USD | 37.0% |
2022 Q3 | 20.54 Million USD | 7.44% |
2022 FY | 80.77 Million USD | 0.0% |
2022 Q4 | 19.72 Million USD | -3.97% |
2022 Q1 | 20.32 Million USD | 1.36% |
2022 Q2 | 19.12 Million USD | -5.92% |
2021 Q1 | 16.59 Million USD | 29.1% |
2021 Q4 | 20.05 Million USD | 68.79% |
2021 Q3 | 11.88 Million USD | -8.29% |
2021 Q2 | 12.95 Million USD | -21.92% |
2020 Q4 | 12.85 Million USD | -35.84% |
2020 Q3 | 20.03 Million USD | -13.08% |
2020 Q2 | 23.04 Million USD | -22.49% |
2020 Q1 | 29.73 Million USD | 61.66% |
2020 FY | 53.96 Million USD | -30.1% |
2019 Q3 | 9.16 Million USD | 0.0% |
2019 Q4 | 18.39 Million USD | 100.69% |
2019 FY | 77.2 Million USD | 0.0% |
2017 FY | 19.14 Million USD | 43.47% |
2016 FY | 13.34 Million USD | 11.63% |
2015 FY | 11.95 Million USD | 29.07% |
2014 FY | 9.26 Million USD | 4.87% |
2013 FY | 8.83 Million USD | -18.01% |
2012 FY | 10.77 Million USD | 1.08% |
2011 FY | 10.65 Million USD | 35.14% |
2010 FY | 7.88 Million USD | 50.68% |
2009 FY | 5.23 Million USD | -11.52% |
2008 FY | 5.91 Million USD | 2.81% |
2007 FY | 5.75 Million USD | -34.27% |
2006 FY | 8.75 Million USD | -9.03% |
2005 FY | 9.62 Million USD | 0.0% |
2003 FY | 4.86 Million USD | 2772.4% |
2002 FY | 169.38 Thousand USD | -74.72% |
2001 FY | 670 Thousand USD | 771.65% |
2000 FY | 76.86 Thousand USD | -67.39% |
1999 FY | 235.7 Thousand USD | -36.6% |
1998 FY | 371.78 Thousand USD | 282.65% |
1997 FY | 97.15 Thousand USD | -30.01% |
1996 FY | 138.81 Thousand USD | 9.69% |
1995 FY | 126.54 Thousand USD | -54.56% |
1994 FY | 278.47 Thousand USD | 33.93% |
1993 FY | 207.92 Thousand USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Acutus Medical, Inc. | 11.22 Million USD | -619.701% |
Cerus Corporation | 143.15 Million USD | 43.572% |
OrthoPediatrics Corp. | 137.01 Million USD | 41.045% |
PetVivo Holdings, Inc. | 11.36 Million USD | -611.03% |
Talis Biomedical Corporation | 67.18 Million USD | -20.232% |
Vivos Therapeutics, Inc. | 24.94 Million USD | -223.816% |
Inogen, Inc. | 236.08 Million USD | 65.784% |
Spectral AI, Inc. | 20.86 Million USD | -287.17% |
Nano-X Imaging Ltd. | 55.99 Million USD | -44.256% |
CVRx, Inc. | 76.14 Million USD | -6.09% |
DIH Holding US, Inc. Warrants | 3.52 Million USD | -2189.663% |
Helius Medical Technologies, Inc. | 12.48 Million USD | -546.803% |
Orthofix Medical Inc. | 667.42 Million USD | 87.897% |
Venus Concept Inc. | 80.47 Million USD | -0.377% |
Accelerate Diagnostics, Inc. | 56.57 Million USD | -42.775% |
Bioventus Inc. | 409.91 Million USD | 80.294% |
BrainsWay Ltd. | 28.01 Million USD | -188.312% |
Envoy Medical, Inc. | 17.89 Million USD | -351.331% |
electroCore, Inc. | 32.03 Million USD | -152.191% |
IceCure Medical Ltd | 16.87 Million USD | -378.663% |
Lucid Diagnostics Inc. | 42.43 Million USD | -90.373% |
Monogram Orthopaedics, Inc. | 17.63 Million USD | -358.113% |
MaxCyte, Inc. | 84.84 Million USD | 4.792% |
NeuroOne Medical Technologies Corporation | 12.41 Million USD | -550.828% |
Nexalin Technology, Inc. | 5.78 Million USD | -1297.237% |
PAVmed Inc | 64.82 Million USD | -24.607% |
Rapid Micro Biosystems, Inc. | 51.07 Million USD | -58.149% |
RxSight, Inc. | 103.85 Million USD | 22.215% |
Sight Sciences, Inc. | 126.44 Million USD | 36.117% |
SI-BONE, Inc. | 156.35 Million USD | 48.335% |
TELA Bio, Inc. | 84.18 Million USD | 4.048% |
TriSalus Life Sciences, Inc. | 70.05 Million USD | -15.307% |
Treace Medical Concepts, Inc. | 203.36 Million USD | 60.279% |
LivaNova PLC | 843.54 Million USD | 90.424% |
908 Devices Inc. | 68.08 Million USD | -18.653% |
Alphatec Holdings, Inc. | 483.59 Million USD | 83.296% |
Nemaura Medical Inc. | 7.13 Million USD | -1031.551% |
NeuroPace, Inc. | 75.29 Million USD | -7.282% |
LENSAR, Inc. | 33.33 Million USD | -142.318% |
Apyx Medical Corporation | 51.01 Million USD | -58.335% |
Cutera, Inc. | 197.72 Million USD | 59.145% |
STRATA Skin Sciences, Inc. | 24.78 Million USD | -225.972% |
BioSig Technologies, Inc. | 28.53 Million USD | -183.138% |
Anika Therapeutics, Inc. | 191.47 Million USD | 57.812% |
ClearPoint Neuro, Inc. | 36.06 Million USD | -124.013% |
Integra LifeSciences Holdings Corporation | 836.39 Million USD | 90.342% |
Axonics, Inc. | 270.2 Million USD | 70.104% |
Outset Medical, Inc. | 198.77 Million USD | 59.36% |
IRIDEX Corporation | 31.81 Million USD | -153.911% |
PROCEPT BioRobotics Corporation | 180.21 Million USD | 55.177% |
IRadimed Corporation | 30.12 Million USD | -168.166% |
Tivic Health Systems, Inc. | 8.53 Million USD | -846.779% |
INVO Bioscience, Inc. | 7.85 Million USD | -928.603% |
Telesis Bio, Inc. | 63.48 Million USD | -27.233% |
Viemed Healthcare, Inc. | 98.45 Million USD | 17.951% |
Varex Imaging Corporation | 224.8 Million USD | 64.066% |
Quipt Home Medical Corp. | 148.66 Million USD | 45.664% |
Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -589.066% |
Pulmonx Corporation | 112.68 Million USD | 28.315% |
Dynatronics Corporation | 9.9 Million USD | -715.291% |
Modular Medical, Inc. | 17.52 Million USD | -360.832% |
ReShape Lifesciences Inc. | 20.18 Million USD | -300.155% |
Semler Scientific, Inc. | 38.94 Million USD | -107.424% |
InMode Ltd. | 215.68 Million USD | 62.547% |
Bruker Corporation | 1.07 Billion USD | 92.495% |
Cytosorbents Corporation | 48.33 Million USD | -67.117% |
DexCom, Inc. | 1.69 Billion USD | 95.224% |
Align Technology, Inc. | 2.07 Billion USD | 96.11% |
Viveve Medical, Inc. | 22.17 Million USD | -264.313% |
ZimVie Inc. | 275.12 Million USD | 70.639% |
Movano Inc. | 29.69 Million USD | -172.076% |
Cytek Biosciences, Inc. | 137.27 Million USD | 41.153% |
Nexalin Technology, Inc. | 5.78 Million USD | -1297.237% |
DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -2189.663% |
Tandem Diabetes Care, Inc. | 600.92 Million USD | 86.557% |
Profound Medical Corp. | 33.6 Million USD | -140.392% |
Insulet Corporation | 939.9 Million USD | 91.406% |
enVVeno Medical Corporation | 25.23 Million USD | -220.07% |
Surmodics, Inc. | 98.69 Million USD | 18.154% |
iCAD, Inc. | 22.22 Million USD | -263.461% |
Nuwellis, Inc. | 22.61 Million USD | -257.225% |
Biotricity, Inc. | 17.18 Million USD | -370.069% |
iRhythm Technologies, Inc. | 445.88 Million USD | 81.884% |
Aethlon Medical, Inc. | 12.27 Million USD | -557.945% |
InspireMD, Inc. | 22.95 Million USD | -251.979% |
PAVmed Inc. | 64.82 Million USD | -24.607% |
BIOLASE, Inc. | 34.66 Million USD | -133.055% |
Beyond Air, Inc. | 61.7 Million USD | -30.923% |
FONAR Corporation | 28.6 Million USD | -182.399% |
AxoGen, Inc. | 149.33 Million USD | 45.908% |
Vivani Medical, Inc. | 26.96 Million USD | -199.571% |
Tactile Systems Technology, Inc. | 177.09 Million USD | 54.386% |
Inari Medical, Inc. | 448.59 Million USD | 81.993% |
UFP Technologies, Inc. | 58.08 Million USD | -39.061% |
QT Imaging Holdings, Inc. | 4.92 Million USD | -1539.322% |
Heart Test Laboratories, Inc. | 6.31 Million USD | -1178.498% |
Tenon Medical, Inc. | 16.96 Million USD | -376.068% |
Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -992.645% |
Co-Diagnostics, Inc. | 44.1 Million USD | -83.161% |
AdaptHealth Corp. | 1.07 Billion USD | 92.506% |
Sintx Technologies, Inc. | 15.2 Million USD | -431.407% |
NanoVibronix, Inc. | 4.97 Million USD | -1524.356% |
Quanterix Corporation | 118.1 Million USD | 31.601% |
Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -589.066% |
Sensus Healthcare, Inc. | 14.44 Million USD | -459.335% |
Pacific Biosciences of California, Inc. | 392.66 Million USD | 79.428% |
TransMedics Group, Inc. | 182.82 Million USD | 55.815% |
ReWalk Robotics Ltd. | 28.06 Million USD | -187.829% |
NeuroMetrix, Inc. | 11.09 Million USD | -627.811% |
Hyperfine, Inc. | 52.87 Million USD | -52.783% |
Establishment Labs Holdings Inc. | 172 Million USD | 53.036% |
Biomerica, Inc. | 6.97 Million USD | -1057.627% |
Bone Biologics Corporation | 9.42 Million USD | -756.774% |
Bluejay Diagnostics, Inc. | 10.31 Million USD | -683.411% |
Silk Road Medical, Inc | 186.35 Million USD | 56.654% |